Headlines about Varex Imaging (NASDAQ:VREX) have been trending positive on Friday, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Varex Imaging earned a news impact score of 0.30 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.0567315386588 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. upgraded shares of Varex Imaging from an “underweight” rating to a “neutral” rating in a report on Wednesday, December 20th. Zacks Investment Research upgraded shares of Varex Imaging from a “strong sell” rating to a “buy” rating and set a $45.00 target price for the company in a report on Saturday, December 23rd. Finally, Jefferies Group raised their target price on shares of Varex Imaging to $39.00 and gave the stock a “buy” rating in a report on Friday, November 10th.
Shares of Varex Imaging (NASDAQ VREX) opened at $40.20 on Friday. Varex Imaging has a 1-year low of $25.00 and a 1-year high of $41.99. The company has a debt-to-equity ratio of 1.22, a current ratio of 3.26 and a quick ratio of 1.72.
Varex Imaging (NASDAQ:VREX) last issued its earnings results on Thursday, November 9th. The company reported $0.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The business had revenue of $216.00 million for the quarter, compared to the consensus estimate of $213.73 million. The business’s revenue for the quarter was up 25.5% compared to the same quarter last year. analysts expect that Varex Imaging will post 1.92 earnings per share for the current fiscal year.
In related news, insider Sunny Sanyal sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $36.50, for a total value of $1,825,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
COPYRIGHT VIOLATION NOTICE: “Positive Media Coverage Somewhat Unlikely to Impact Varex Imaging (VREX) Stock Price” was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://transcriptdaily.com/2018/01/05/positive-media-coverage-somewhat-unlikely-to-impact-varex-imaging-vrex-stock-price.html.
Varex Imaging Company Profile
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.